T Hofmann, O Bohmer, G Huls, HG Terbrack, P Bittner, V Klingmuller, E Heerd and H Lindemann
Department of Allergology and Pneumology of Justus-Liebig-Universitat Children's Hospital, Giessen, Germany.

Cystic fibrosis (CF) is associated with impaired ion transport across epithelial membranes and an increased transepithelial potential difference (PD) that can be measured in airway epithelium. The aim of this study was to investigate the diagnostic value of nasal PD in CF, and to test a modified approach to the measurement of this PD. The reproducibility and diagnostic sensitivity and specificity of nasal PD measurements were tested with the perfusion technique and with a simplified modification of the technique done with a novel, solid-state exploring electrode. With the perfusion method, basal PD values were different in CF patients (mean +/- SEM: -51.6 +/- 0.9 mV, n = 104) than in normal (-15.5 +/- 0.9 mV, n = 58, p < 0.01) subjects. CF patients with acute rhinitis or other nasal pathology had mean PD values that were intermediate between those of the patients and normal and disease- control groups (-28.3 +/- 1.2 mV, n = 40, p < 0.01, different from normal). The diagnostic sensitivity of the perfusion method for CF was 91.3%, and the specificity was 96.4%. PD measurements with the modified technique correlated highly with the results achieved with the perfusion method (r = 0.94, n +/- 158). The measurement of nasal PD effectively distinguishes CF from control subjects. Care must be taken in the interpretation of measurements made on acutely inflamed epithelium. The modified method was simpler than the conventional perfusion technique, and equally effective.

This article has been cited by other articles:

				K De Boeck, M Wilschanski, C Castellani, C Taylor, H Cuppens, J Dodge, M Sinaasappel, and on behalf of the Diagnostic Working Group Cystic fibrosis: terminology and diagnostic algorithms Thorax, July 1, 2006; 61(7): 627 - 635. [Abstract] [Full Text] [PDF]

				I. C. Davis, E. R. Lazarowski, J. M. Hickman-Davis, J. A. Fortenberry, F.-P. Chen, X. Zhao, E. Sorscher, L. M. Graves, W. M. Sullender, and S. Matalon Leflunomide Prevents Alveolar Fluid Clearance Inhibition by Respiratory Syncytial Virus Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 673 - 682. [Abstract] [Full Text] [PDF]

				M. E. Mycielska and M. B. A. Djamgoz Cellular mechanisms of direct-current electric field effects: galvanotaxis and metastatic disease J. Cell Sci., May 1, 2004; 117(9): 1631 - 1639. [Abstract] [Full Text] [PDF]

				M. P. Boyle, M. Diener-West, L. Milgram, M. Knowles, C. Foy, P. Zeitlin, and T. Standaert A Multicenter Study of the Effect of Solution Temperature on Nasal Potential Difference Measurements Chest, August 1, 2003; 124(2): 482 - 489. [Abstract] [Full Text] [PDF]

				C. Sartori, Y. Allemann, H. Duplain, M. Lepori, M. Egli, E. Lipp, D. Hutter, P. Turini, O. Hugli, S. Cook, et al. Salmeterol for the Prevention of High-Altitude Pulmonary Edema N. Engl. J. Med., May 23, 2002; 346(21): 1631 - 1636. [Abstract] [Full Text] [PDF]

				I. Fajac, J. Lacronique, A. Lockhart, J. Dall'Ava-Santucci, and D. J Dusser Silver/silver chloride electrodes for measurement of potential difference in human bronchi Thorax, October 1, 1998; 53(10): 879 - 881. [Abstract] [Full Text]

				U. PRADAL, C. CASTELLANI, A. DELMARCO, and G. MASTELLA Nasal Potential Difference in Congenital Bilateral Absence of the Vas Deferens Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 896 - 901. [Abstract] [Full Text] [PDF]

				T. HOFMANN, M. J. STUTTS, A. ZIERSCH, C. RUCKES, W. M. WEBER, M. R. KNOWLES, H. LINDEMANN, and R. C. BOUCHER Effects of Topically Delivered Benzamil and Amiloride on Nasal Potential Difference in Cystic Fibrosis Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1844 - 1849. [Abstract] [Full Text] [PDF]